The clinical efficacy of a succinate-containing infusion drug during pharmacotherapy for hepatic lesions of varying genesis: results of meta-analysis
AIM: To pool the published results of trials of the new infusion hepatoprotector remaxol for the integral quantification of the magnitude of its clinical efficacy/MATERIAL AND METHODS: The authors made a systematized review of the published results of randomized clinical trials of the succinate-cont...
Main Authors: | N K Mazina, P V Mazin, D S Sukhanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2013-01-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31198 |
Similar Items
-
Current aspects of pathogenetic therapy in tuberculosis
by: Goar Sisakovna Balasanyants, et al.
Published: (2011-08-01) -
Infusion Antihypoxants in Children with Critical Conditions
by: Yu. S. Aleksandrovich, et al.
Published: (2014-06-01) -
Hepatotropic medicines: current status
by: Sergey Vladimirovich Okovityy, et al.
Published: (2012-02-01) -
USE OF HEPATOPROTECTORS IN PATIENTS WITH OVARIAN CANCER
by: S. V. Tumanyan, et al.
Published: (2015-05-01) -
Efficacy of the infusion hepatotropic drug remaxol in the pathogenetic therapy for cirrhotic stage chronic viral hepatitides
by: V V Stelmakh, et al.
Published: (2015-08-01)